project id: TCGA-GBM; case submitter id: TCGA-74-6575; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 73; days to birth: -26827; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1936; age at diagnosis: 26827; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 636.0; icd 10 code: C71.9; last known disease status: not reported; morphology: 9440/3; primary diagnosis: Glioblastoma; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Brain, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Brain, NOS; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 1.0; longest dimension: 1.8; preservation method: Unknown; shortest dimension: 0.8; sample id: cfc29132-36a8-46e6-8341-70005a3e208c; sample submitter id: TCGA-74-6575-01A; portion id: bb94817e-6c83-4514-bc12-9b4b575f862c; portion submitter id: TCGA-74-6575-01A-11; slide id: 177ed09d-613d-4b16-a620-10ef551be2d2; slide submitter id: TCGA-74-6575-01A-01-TS1; percent necrosis: 5.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 95.0; percent tumor nuclei: 75.0; section location: TOP;